Thursday, April 8, 2021

Advertising

Home Business News McPherson’s rejects Geminder’s $172 million bid

McPherson’s rejects Geminder’s $172 million bid


“[Our share price] has been impacted by the effect of COVID-19 on cross-border e-commerce into China and like all things with COVID-19, hopefully, will pass,” he said. “Then the negative drag on our results and share price will be removed.”

McPherson’s board has advised shareholders in the 48-page statement, released on Thursday, to await the completion of the operational review into the business.

However, Gallin has called on McPherson’s to provide a trading update before May and give more clarity on the performance of its recent $27 million acquisition of vitamins brand Global Therapeutics.

McPherson’s newly-minted chief executive Grant Peck said the company would wait until it had further certainty about its performance in…



Click here to view the original article.

- Advertisment -
- Advertisment -

Recently Viewed

You might also like ...

The Tietto Minerals (ASX:TIE) share price is up 8% today. Here’s why
Article feature image
AstraZeneca COVID-19 vaccine blood clotting cause still ‘unknown’. But the maths is simple – ABC News